|
Volumn 454, Issue 1-2, 1999, Pages 27-30
|
Thiazolidinedione inhibits the production of monocyte chemoattractant protein-1 in cytokine-treated human vascular endothelial cells
|
Author keywords
Human vascular endothelial cell; Interleukin 1 ; Monocyte chemoattractant protein 1; Thiazolidinedione; Tumor necrosis factor
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
INTERLEUKIN 1BETA;
MESSENGER RNA;
MONOCYTE CHEMOTACTIC PROTEIN 1;
PIRINIXIC ACID;
THIAZOLIDINE DERIVATIVE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ARTICLE;
ATHEROSCLEROSIS;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GENETIC TRANSCRIPTION;
GENETIC TRANSFECTION;
HUMAN;
HUMAN CELL;
NORTHERN BLOTTING;
PRIORITY JOURNAL;
PROMOTER REGION;
PROTEIN EXPRESSION;
PROTEIN INDUCTION;
VASCULAR ENDOTHELIUM;
CHEMOKINE CCL2;
CYTOKINES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDOTHELIUM, VASCULAR;
HUMANS;
INTERLEUKIN-1;
PROMOTER REGIONS (GENETICS);
PYRIMIDINES;
THIAZOLES;
THIAZOLIDINEDIONES;
TIME FACTORS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0032988209
PISSN: 00145793
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-5793(99)00765-6 Document Type: Article |
Times cited : (88)
|
References (22)
|